Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05558696
PHASE2

A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004)

Sponsor: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)

View on ClinicalTrials.gov

Summary

This study will evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics of the orally administered lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat, in participants with polycythemia vera (PV). At Week 36 of dosing, participants will be assessed for eligibility to receive additional treatment through Week 52. Participants deriving clinical benefit and safely tolerating bomedemstat will qualify for continued treatment at the Investigator's discretion.

Official title: A Phase 2 Multi-Center, Open Label Study to Assess the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Bomedemstat in Patients With Polycythemia Vera (PV)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2023-09-07

Completion Date

2025-07-10

Last Updated

2026-05-07

Healthy Volunteers

No

Interventions

DRUG

Bomedemstat

Oral capsule

Locations (17)

BRCR Global ( Site 0120)

Plantation, Florida, United States

Hematology Oncology of the North Shore ( Site 0104)

Skokie, Illinois, United States

University of Michigan Comprehensive Cancer Center ( Site 0008)

Ann Arbor, Michigan, United States

Comprehensive Cancer Centers of Nevada - Peak ( Site 0118)

Las Vegas, Nevada, United States

Duke University Medical Center ( Site 0016)

Durham, North Carolina, United States

Ohio State University Comprehensive Cancer Center ( Site 0103)

Columbus, Ohio, United States

OHSU Knight Cardiovascular Institute Cardiology Clinic - South Waterfront ( Site 0102)

Portland, Oregon, United States

Huntsman Cancer Hospital at the University of Utah ( Site 0119)

Salt Lake City, Utah, United States

Sunshine Coast Hematology and Oncology Clinic (Site 0506)

Sunshine Coast, Queensland, Australia

Monash Medical Centre ( Site 0006)

Clayton, Victoria, Australia

Royal Perth Hospital ( Site 0504)

Perth, Western Australia, Australia

Gloucestershire Royal Hospital ( Site 0205)

Gloucester, England, United Kingdom

United Lincolnshire Hospitals NHS Trust ( Site 0204)

Lincoln, Great Britain, United Kingdom

Imperial College London ( Site 0025)

London, Great Britain, United Kingdom

Boston Pilgrim Hospital ( Site 0207)

Boston, Lincolnshire, United Kingdom

Guys and St Thomas NHS Foundation Trust - Guys Hospital ( Site 0020)

London, London, City of, United Kingdom

Royal Gwent Hospital ( Site 0201)

Newport, Wales, United Kingdom